| scholarly article | Q13442814 |
| P2093 | author name string | Raja Rajalingam | |
| P2860 | cites work | Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor | Q73370002 |
| Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation | Q73524014 | ||
| Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies | Q73615692 | ||
| Xenogeneic transplantation | Q74578140 | ||
| Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles | Q74754476 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B | Q79445104 | ||
| Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets | Q79984905 | ||
| Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells | Q80241947 | ||
| Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation | Q80679597 | ||
| Role of natural killer cell subsets in cardiac allograft rejection | Q82515006 | ||
| KIR-HLA mismatching in human renal allograft transplantation: emergence of a new concept | Q84468922 | ||
| KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation | Q84468930 | ||
| Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition | Q85176243 | ||
| Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies | Q21131216 | ||
| Mechanisms involved in antibody- and complement-mediated allograft rejection | Q24629268 | ||
| Plasticity in the organization and sequences of human KIR/ILT gene families | Q24676718 | ||
| Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B | Q27675174 | ||
| KIR: diverse, rapidly evolving receptors of innate and adaptive immunity | Q28203441 | ||
| Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells | Q28205984 | ||
| Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS | Q28215577 | ||
| In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
| Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
| Innate or adaptive immunity? The example of natural killer cells | Q29615106 | ||
| NK cell recognition | Q29615107 | ||
| Fcgamma receptors as regulators of immune responses | Q29615584 | ||
| Innate lymphoid cells--a proposal for uniform nomenclature | Q29617431 | ||
| Biology of natural killer cells | Q29619728 | ||
| Pathways of antigen processing | Q33631854 | ||
| Inhibitory pathways triggered by ITIM-containing receptors. | Q33653653 | ||
| Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans | Q33909456 | ||
| Regulation of the natural killer cell receptor repertoire | Q34178144 | ||
| Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals | Q34471812 | ||
| CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells | Q34688644 | ||
| Variable receptors controlling activation and inhibition of NK cells | Q34786959 | ||
| Diagnosis and management of antibody-mediated rejection: current status and novel approaches | Q34841849 | ||
| New aspects of natural-killer-cell surveillance and therapy of cancer | Q34988265 | ||
| The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. | Q35030951 | ||
| What does it take to make a natural killer? | Q35136013 | ||
| Natural killer cell receptor signaling | Q35145778 | ||
| Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. | Q35152823 | ||
| Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. | Q35847425 | ||
| A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature | Q35900982 | ||
| Antibody-mediated rejection in kidney transplantation: a review | Q35915453 | ||
| Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism | Q36007647 | ||
| MHC class I molecules and KIRs in human history, health and survival | Q36047157 | ||
| Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment | Q36190723 | ||
| NK cells promote transplant tolerance by killing donor antigen-presenting cells | Q36228823 | ||
| Antibody-mediated organ-allograft rejection | Q36263023 | ||
| Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function | Q36371748 | ||
| How do natural killer cells find self to achieve tolerance? | Q36424804 | ||
| The changing role of natural killer cells in solid organ rejection and tolerance | Q36434396 | ||
| Potent antibody therapeutics by design | Q36452621 | ||
| IPD--the Immuno Polymorphism Database. | Q36491455 | ||
| HLA alleles determine differences in human natural killer cell responsiveness and potency | Q36498481 | ||
| Self-tolerance of natural killer cells | Q36518933 | ||
| KIR and disease: a model system or system of models? | Q36652201 | ||
| Human natural killer cells | Q36787596 | ||
| Keeping NK cells in highly regulated antiviral warfare | Q36805101 | ||
| MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response | Q36868743 | ||
| Line of attack: NK cell specificity and integration of signals | Q36930253 | ||
| Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells | Q37142163 | ||
| Adaptive immune features of natural killer cells | Q37172503 | ||
| Variable interactions of recipient killer cell immunoglobulin-like receptors with self and allogenic human leukocyte antigen class I ligands may influence the outcome of solid organ transplants | Q37236988 | ||
| Natural killer cells and the immune response in solid organ transplantation | Q37721482 | ||
| Human diversity of killer cell immunoglobulin-like receptors and disease | Q37977062 | ||
| The impact of donor-specific anti-HLA antibodies on late kidney allograft failure | Q38003049 | ||
| Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. | Q38104708 | ||
| The Role of Natural Killer Cells in Humoral Rejection | Q38505056 | ||
| Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands | Q40065415 | ||
| Human NK cell education by inhibitory receptors for MHC class I. | Q40244934 | ||
| Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells | Q40333010 | ||
| KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand | Q40364675 | ||
| Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response | Q40536409 | ||
| Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors | Q40605227 | ||
| Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506. | Q41095197 | ||
| Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation | Q41122587 | ||
| Allogeneic heart transplantation activates alloreactive NK cells | Q41134817 | ||
| Effects of rapamycin on human HLA-unrestricted cell killing | Q41601011 | ||
| KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. | Q41985731 | ||
| Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. | Q42596148 | ||
| HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 | ||
| Natural Killer Cells Mediate Long-term Kidney Allograft Injury | Q43445575 | ||
| Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. | Q43830010 | ||
| Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans | Q44078600 | ||
| Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells | Q44396781 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells | Q45046743 | ||
| Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model | Q45251857 | ||
| Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferation | Q45308909 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Global diversity and evidence for coevolution of KIR and HLA. | Q46442901 | ||
| Licensing of natural killer cells by host major histocompatibility complex class I molecules | Q46634172 | ||
| Epigenetic control of highly homologous killer Ig-like receptor gene alleles | Q46764003 | ||
| Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. | Q47254808 | ||
| Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations | Q47700353 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Predicting kidney graft failure by HLA antibodies: a prospective trial. | Q51038562 | ||
| NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. | Q51676450 | ||
| Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. | Q53060554 | ||
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients. | Q53305558 | ||
| Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. | Q54288133 | ||
| Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 | ||
| "Hyperacute" renal-homograft rejection in man. | Q54626072 | ||
| A Longitudinal Study of the Influence of Azathioprine on Natural Killer Cell Activity | Q59326517 | ||
| Human NK-cell receptors | Q61719167 | ||
| Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28−/− mice | Q63968512 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| Activation of alloreactive natural killer cells is resistant to cyclosporine | Q73302946 | ||
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | 585 | |
| P577 | publication date | 2016-12-19 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection | |
| P478 | volume | 7 |
| Q47343260 | Broad Impairment of Natural Killer Cells from Operationally Tolerant Kidney Transplanted Patients. |
| Q90148215 | Enhancing Natural Killer and CD8+ T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8+ T Cells with HLA-E Monospecific Monoclonal Antibodies |
| Q50176867 | Fatal accelerated rejection with a prominent natural killer cell infiltrate in a heart transplant recipient with peripartum cardiomyopathy |
| Q98906910 | Human immunology and immunotherapy: main achievements and challenges |
| Q55444585 | Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura. |
| Q58092158 | Natural killer cells in lung transplantation |
| Q92263588 | Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma |
| Q64111584 | Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions |
| Q90429892 | Xenotransplantation: Progress Along Paths Uncertain from Models to Application |
Search more.